Document Detail

EANM Dosimetry Committee Series on Standard Operational Procedures for Pre-Therapeutic Dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases.
MedLine Citation:
PMID:  23576099     Owner:  NLM     Status:  Publisher    
The EANM Dosimetry Committee Series "Standard Operational Procedures for Pre-Therapeutic Dosimetry" (SOP) provides advice to scientists and clinicians on how to perform patient-specific absorbed dose assessments. This particular SOP describes how to tailor the therapeutic activity to be administered for radioiodine therapy of benign thyroid diseases such as Graves' disease or hyperthyroidism. Pretherapeutic dosimetry is based on the assessment of the individual (131)I kinetics in the target tissue after the administration of a tracer activity. The present SOP makes proposals on the equipment to be used and guides the user through the measurements. Time schedules for the measurement of the fractional (131)I uptake in the diseased tissue are recommended and it is shown how to calculate from these datasets the therapeutic activity necessary to administer a predefined target dose in the subsequent therapy. Potential sources of error are pointed out and the inherent uncertainties of the procedures depending on the number of measurements are discussed. The theoretical background and the derivation of the listed equations from compartment models of the iodine kinetics are explained in a supplementary file published online only.
Heribert Hänscheid; Cristina Canzi; Wolfgang Eschner; Glenn Flux; Markus Luster; Lidia Strigari; Michael Lassmann
Related Documents :
23644949 - Phenotypic screens for compounds that target the cellular pathologies underlying parkin...
24898649 - Autonomic dysfunction in alzheimer's disease: tools for assessment and review of the li...
21441819 - Generalized subcutaneous edema as a rare manifestation of dermatomyositis: clinical les...
23204959 - Percutaneous fasciotomy for the treatment of dupuytren's disease-a systematic review.
23600759 - Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.
24882539 - Risk stratification and selection for statin therapy: going beyond framingham.
16571859 - Adiponectin, visceral fat, oxidative stress, and early macrovascular disease: the coron...
25426969 - Diverticular disease: evolving concepts in classification, presentation, and management.
2160899 - Cytomegalovirus-associated acute pancreatic disease in patients with acquired immunodef...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-4-11
Journal Detail:
Title:  European journal of nuclear medicine and molecular imaging     Volume:  -     ISSN:  1619-7089     ISO Abbreviation:  Eur. J. Nucl. Med. Mol. Imaging     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-4-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101140988     Medline TA:  Eur J Nucl Med Mol Imaging     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Nuclear Medicine, University of Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Taï chimpanzees use botanical skills to discover fruit: what we can learn from their mistakes.
Next Document:  Neuroradiological advances detect abnormal neuroanatomy underlying neuropsychological impairments: t...